PTV margin for dose escalated radiation therapy of prostate cancer with daily on-line realignment using internal fiducial markers: Monte Carlo approach and dose population histogram (DPH) analysis

Journal of Applied Clinical Medical Physics

Volumn 7, Issue 2, 2006, Pages 38-49

  Zhang, Miao ^a   Moiseenko, Vitali ^a   Liu, Mitchell ^a  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

Author keywords

Biological factors; Dose population histogram; Organ motion simulation; Patient realignment; Prostate cancer dose escalation

Indexed keywords

ARTICLE; COMPUTER SIMULATION; EVALUATION; HUMAN; MALE; MONTE CARLO METHOD; PATHOLOGY; PROSTATE TUMOR; RADIATION DOSE; RADIATION RESPONSE;

COMPUTER SIMULATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; MONTE CARLO METHOD; PROSTATIC NEOPLASMS; RADIATION DOSAGE;

EID: 34548242211     PISSN: None     EISSN: 15269914     Source Type: Journal    
DOI: 10.1120/jacmp.v7i2.2210     Document Type: Article

References (28)

1. Liu M, Pickles T, Agranovich A, et al. Impact of neoadjuvant androgen ablation and other factors on late toxicity after external beam prostate radiotherapy. Int J Radiat Oncol Biol Phys. 2004;58:59-67.
2. Schultheiss TE, Lee WR, Hunt MA, Hanlon AL, Peter RS, Hanks CE. Late GI and GU complications in the treatment of prostate cancer. Int J Radiat Oncol Biol Phys. 1997;37:3-11.
3. Hanks GE, Schultheiss TE, Hanlon AL, et al. Optimization of conformal radiation treatment of prostate cancer: Report of a dose escalation study. Int J Radiat Oncol Biol Phys. 1997;37:543-550.
4. Boersma LJ, van den Brink M, Bruce AM. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 1998;41:83-92.
5. Sandler HM, McLaughlin PW, Ten haken RK. Three dimensional conformal radiotherapy for the treatment of prostate cancer: Low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys. 1995;33:797-801.
6. Zelefsky MJ, Leibel SA, Gaudin PB. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 1998;41:491-500.
7. van Herk M, Remeijer P, Rasch C, Lebesque JV. The probability of correct target dosage: Dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 2000;47:1121-1135.
8. Chung PW, Haycocks T, Brown T, et al. On-line aSi portal imaging of implanted fiducial markers for the reduction of interfraction error during conformal radiotherapy of prostate carcinoma. Int J Radiat Oncol Biol Phys. 2004;60:329-334.
9. Zhang M, Moiseenko VM, Liu M, Craig T. Internal fiducial markers can assist dose escalation in treatment of prostate cancer: Result of organ motion simulations. Phys Med Biol. 2006;51:269-285.
10. Cheung R, Tucker SL, Ye JS, et al. Characterization of rectal normal tissue complication probability after high-dose external beam radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys. 2004;58:1513-1519.
11. Rancati T, Fiorino C, Gagliardi G, et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol. 2004;73:21-32.
12. Emami B, Lyman J, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys. 1991;21:109-122.
13. Burman C, Kutcher GJ, Emami B, Goitein M. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys. 1991;21:123-135.
14. Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys. 2003;30:979-985.
15. Craig T, Battista J, Van Dyk J. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. I. The effect of shift invariance. Med Phys. 2003;30:2001-2011.
16. Craig T, Battista J, Van Dyk J. Limitations of a convolution method for modeling geometric uncertainties in radiation therapy. II. The effect of a finite number of fractions. Med Phys. 2003;30:2012-2020.
17. van Herk M, Witte M, van der Geer J, Schneider C, Lebesque JV. Biologic and physical fractionation effects of random geometric errors. Int J Radiat Oncol Biol Phys. 2003;57:1460-1471.
18. Okunieff P, Morgan D, Niemierko A, Suit HD. Radiation dose-response of human tumors. Int J Radiat Oncol Biol Phys. 1995;32:1227-1237.
19. Fowler JF, Ritter MA, Chappell RJ, Brenner DJ. What hypofractionated protocols should be tested for prostate cancer? Int J Radiat Oncol Biol Phys. 2003;56:1093-1104.
20. Kutcher GJ, Burman C. Calculation of complication probability factors for non-uniform normal tissue irradiation: The effective volume method. Int J Radiat Oncol Biol Phys. 1989; 16:1623-1630.
21. Lyman JT, Wolbarst AB. Optimization of radiation therapy, IV: A dose-volume histogram reduction algorithm. Int J Radiat Oncol Biol Phys. 1989;17:433-436.
22. Wang L, Jacob R, Chen L, et al. Stereotactic IMRT for prostate cancer: Setup accuracy of a new stereotactic body localization system. J Appl Clin Med Phys. 2004;5:18-28.
23. Cheung R, Tucker S, Lee AK, et al. Dose-response characteristics of low- and intermediate-risk prostate cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys. 2005;61:993-1002.
24. Teh BS, McGary JE, Dong L, et al. The use of rectal balloon during the delivery of intensity modulated radiotherapy (IMRT) for prostate cancer: More than just a prostate gland immobilization device? Cancer J. 2002;8:476-483.
25. Britton KR, Takai Y, Mitsuya M, Nemoto K, Ogawa Y, Yamada S. Evaluation of inter and intrafraction organ motion during intensity modulated radiation therapy (IMRT) for localized prostate cancer measured by a newly developed on-board image-guided system. Radiat Med. 2005;23:14-24.
26. Little DJ, Dong L, Levy LB, Chandra A, Kuban DA. Use of portal images and BAT ultrasonography to measure setup error and organ motion for prostate IMRT: Implications for treatment margins. Int J Radiat Oncol Biol Phys. 2003;56:1218-1224.
27. Skwarchuk MW, Jackson A, Zelefsky MJ, et al. Late rectal toxicity after conformal radiotherapy of prostate cancer (I): Multivariate analysis and dose-response. Int J Radiat Oncol Biol Phys. 2000;47:103-113.
28. Storey MR, Pollack A, Zagars G, Smith L, Antolak J, Rosen I. Complications from radiotherapy dose escalation in prostate cancer: Preliminary results of a randomized trial. Int J Radiat Oncol Biol Phys. 2000;48:635-642.